| Linda Marie Bowersox, APN, MSN | |
|
393 Main St, Paterson, NJ 07501-2815 | |
| (973) 523-0925 | |
| Not Available |
| Full Name | Linda Marie Bowersox |
|---|---|
| Gender | Female |
| Speciality | Nurse Practitioner |
| Experience | 24 Years |
| Location | 393 Main St, Paterson, New Jersey |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1215118773 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 363LA2200X | Nurse Practitioner - Adult Health | NO80337 (New Jersey) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| St Joseph's Hospital And Medical Center | Paterson, NJ | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| St Josephs Medical Group Pc | 8628470325 | 200 |
News Archive
Many chemotherapeutics act by damaging the DNA. Since cancer cells divide more often than most normal cells, they react more sensitive to DNA damaging agents.
The first blood test to diagnose major depression in adults has been developed by Northwestern Medicine- scientists, a breakthrough approach that provides the first objective, scientific diagnosis for depression.
The New York Department of Health (DOH) and public-private partnership New York eHealth Collaborative (NYeC) on Tuesday presented a plan to change the face of health care for all New Yorkers by creating the country's largest network for electronic medical records.
Mersana Therapeutics, a platform-based cancer therapeutics company, today announced that it has initiated a Phase 1 clinical trial to study the safety and pharmacokinetics of XMT-1107 in patients with refractory advanced solid tumors. XMT-1107 is a novel anti-angiogenic fumagillin analog that employs Mersana's Fleximer platform. Mersana's XMT-1001, a conjugate of Fleximer and camptothecin, is currently completing a Phase 1 study.
More than 170 executives from the senior living industry today visited with members of Congress to advocate for policies that will advance quality of life for America's seniors. The Assisted Living Federation of America facilitated the meetings and hosted a briefing about critical matters before Congress that could impact the future of senior living.
› Verified 1 days ago
| Entity Name | St Josephs Healthcare Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1497791297 PECOS PAC ID: 9739171984 Enrollment ID: O20040330001612 |
News Archive
Many chemotherapeutics act by damaging the DNA. Since cancer cells divide more often than most normal cells, they react more sensitive to DNA damaging agents.
The first blood test to diagnose major depression in adults has been developed by Northwestern Medicine- scientists, a breakthrough approach that provides the first objective, scientific diagnosis for depression.
The New York Department of Health (DOH) and public-private partnership New York eHealth Collaborative (NYeC) on Tuesday presented a plan to change the face of health care for all New Yorkers by creating the country's largest network for electronic medical records.
Mersana Therapeutics, a platform-based cancer therapeutics company, today announced that it has initiated a Phase 1 clinical trial to study the safety and pharmacokinetics of XMT-1107 in patients with refractory advanced solid tumors. XMT-1107 is a novel anti-angiogenic fumagillin analog that employs Mersana's Fleximer platform. Mersana's XMT-1001, a conjugate of Fleximer and camptothecin, is currently completing a Phase 1 study.
More than 170 executives from the senior living industry today visited with members of Congress to advocate for policies that will advance quality of life for America's seniors. The Assisted Living Federation of America facilitated the meetings and hosted a briefing about critical matters before Congress that could impact the future of senior living.
› Verified 1 days ago
| Entity Name | St Josephs Medical Group Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1205425519 PECOS PAC ID: 8628470325 Enrollment ID: O20210716000520 |
News Archive
Many chemotherapeutics act by damaging the DNA. Since cancer cells divide more often than most normal cells, they react more sensitive to DNA damaging agents.
The first blood test to diagnose major depression in adults has been developed by Northwestern Medicine- scientists, a breakthrough approach that provides the first objective, scientific diagnosis for depression.
The New York Department of Health (DOH) and public-private partnership New York eHealth Collaborative (NYeC) on Tuesday presented a plan to change the face of health care for all New Yorkers by creating the country's largest network for electronic medical records.
Mersana Therapeutics, a platform-based cancer therapeutics company, today announced that it has initiated a Phase 1 clinical trial to study the safety and pharmacokinetics of XMT-1107 in patients with refractory advanced solid tumors. XMT-1107 is a novel anti-angiogenic fumagillin analog that employs Mersana's Fleximer platform. Mersana's XMT-1001, a conjugate of Fleximer and camptothecin, is currently completing a Phase 1 study.
More than 170 executives from the senior living industry today visited with members of Congress to advocate for policies that will advance quality of life for America's seniors. The Assisted Living Federation of America facilitated the meetings and hosted a briefing about critical matters before Congress that could impact the future of senior living.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Linda Marie Bowersox, APN, MSN 224 Hamburg Turnpike, Wayne, NJ 07470 Ph: (973) 956-3357 | Linda Marie Bowersox, APN, MSN 393 Main St, Paterson, NJ 07501-2815 Ph: (973) 523-0925 |
News Archive
Many chemotherapeutics act by damaging the DNA. Since cancer cells divide more often than most normal cells, they react more sensitive to DNA damaging agents.
The first blood test to diagnose major depression in adults has been developed by Northwestern Medicine- scientists, a breakthrough approach that provides the first objective, scientific diagnosis for depression.
The New York Department of Health (DOH) and public-private partnership New York eHealth Collaborative (NYeC) on Tuesday presented a plan to change the face of health care for all New Yorkers by creating the country's largest network for electronic medical records.
Mersana Therapeutics, a platform-based cancer therapeutics company, today announced that it has initiated a Phase 1 clinical trial to study the safety and pharmacokinetics of XMT-1107 in patients with refractory advanced solid tumors. XMT-1107 is a novel anti-angiogenic fumagillin analog that employs Mersana's Fleximer platform. Mersana's XMT-1001, a conjugate of Fleximer and camptothecin, is currently completing a Phase 1 study.
More than 170 executives from the senior living industry today visited with members of Congress to advocate for policies that will advance quality of life for America's seniors. The Assisted Living Federation of America facilitated the meetings and hosted a briefing about critical matters before Congress that could impact the future of senior living.
› Verified 1 days ago
Susan Mugalu, ANP Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 703 Main St, Paterson, NJ 07503 Phone: 973-754-0000 | |
Diane E Mcclure, CPNP Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 703 Main St, Paterson, NJ 07503 Phone: 973-754-2555 Fax: 973-754-2567 | |
Cynthia Dayrit -demetillo, NP Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 1040 Main St, Paterson, NJ 07503 Phone: 973-782-6615 Fax: 973-782-6618 | |
Mrs. Kathleen Ann Connolly, Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 393 Main St, Paterson, NJ 07501 Phone: 973-523-6220 Fax: 973-825-7201 | |
Mr. Michael Pasquale, MSN, RN, APN-C Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 703 Main St, Paterson, NJ 07503 Phone: 973-754-3857 | |
Nidia Ortega, APN Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 416 Park Ave, Paterson, NJ 07504 Phone: 973-684-8138 Fax: 973-684-0032 | |
Kassidy Katona, APN Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 680 Broadway Ste 104, Paterson, NJ 07514 Phone: 973-239-9400 |